Distal Urethral Cancer
Showing 1 - 7 of 7
Distal Urethral Cancer, Proximal Urethral Cancer, Recurrent Bladder Cancer Trial in United States (afatinib dimaleate,
Recruiting
- Distal Urethral Cancer
- +8 more
- afatinib dimaleate
- laboratory biomarker analysis
-
Atlanta, Georgia
- +5 more
Sep 24, 2021
Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer Trial in
Completed
- Distal Urethral Cancer
- +10 more
- Gemcitabine hydrochloride
- +3 more
-
Springfield, Missouri
- +1 more
Sep 17, 2020
Distal Urethral Cancer, Proximal Urethral Cancer, Squamous Cell Carcinoma of the Bladder Trial in Philadelphia (drug, procedure,
Terminated
- Distal Urethral Cancer
- +5 more
- gemcitabine hydrochloride
- +3 more
-
Philadelphia, Pennsylvania
- +1 more
Jul 26, 2019
Adenocarcinoma of the Bladder, Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter Trial
Terminated
- Adenocarcinoma of the Bladder
- +12 more
- sorafenib tosylate
- laboratory biomarker analysis
-
Boston, MassachusettsEastern Cooperative Oncology Group
May 20, 2014
Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer Trial in
Terminated
- Distal Urethral Cancer
- +8 more
- trastuzumab
-
Chicago, IllinoisCancer and Leukemia Group B
May 1, 2013
Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer, Bone Metastases Trial in Columbus (recombinant interleukin-12,
Completed
- Advanced Adult Primary Liver Cancer
- +126 more
- recombinant interleukin-12
- ABI-007/carboplatin/trastuzumab
-
Columbus, OhioOhio State University Medical Center
Feb 27, 2013
Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer Trial in
Completed
- Distal Urethral Cancer
- +10 more
-
Boston, MassachusettsEastern Cooperative Oncology Group
Jan 23, 2013